2m 2m 2m 2m 2m 2m 2m
Ava Bio (AVAI)
OTC
$0.18-$0.002 (-1.24%)
Price as of Jul 14, 2026- $25.4MMarket Cap
- -66.62%1-Year Change
- Software - ApplicationIndustry
Ava Bio (AVAI)
$0.18-$0.002 (-1.24%)
AVAI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.18 | ||
Change | -$0.002 (-1.24%) | ||
Open | $0.19 | ||
High | $0.19 | ||
Low | $0.15 | ||
Previous Close | $0.19 | ||
Volume | 167,170 | ||
30-Day Average Volume | 117,962 | ||
1-Week Change | 56.98% | ||
1-Month Change | 22.47% | ||
1-Year Change | -66.62% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 138.3M | ||
Total Assets | $572,696.00 | ||
Market Cap | $25.4M | ||
Enterprise Value | $26.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$255,177.00 | ||
Free Cash Flow | -$50,827.00 | ||
EBIT | -$255,177.00 | ||
EBITDA | -$248,659.00 | ||
Net Working Capital | -$3.3M | ||
EPS | -$0.00 | ||
Enterprise Value/EBITDA | -106 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -9 | ||
P/E | -102 | ||
PEG | N/A | ||
Price/Free Cash Flow | -500 | ||
Price/Operating Cash Flow | -500 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue